Search
forResearch 10 of 1000+
- Cyberspace Chat: An Examination of Brand-Name vs Generic Finasteride: A look at Active Pharmaceutical Ingredient (API), Excipients, Bioequivalence, and Other Factors Affecting Efficacy
- Biopharmaceutical Performance of DiluCap: A Line of Functional Excipients Enhancing Dissolution Profiles of Minoxidil, Finasteride, Melatonin, and Naltrexone.
- Formulation and Evaluation of Herbal Hair Gel
- Development and Validation of HPLC Method for Simultaneous Estimation of Minoxidil and Finasteride in Topical Solution
- Using risk analysis to guide changes to compounding formulae
- STABILITY INDICATING AN LC-ESI-MS/MS METHOD FOR THE QUANTIFICATION OF MINOXIDIL IN PHARMACEUTICAL DOSAGE FORMS
- Compatibility Studies of Minoxidil with Different Excipients by Using DSC, TGA and FTIR
- RP-HPLC assay method for simultaneous estimation of tamsulosin hydrochloride and finasteride in pharmaceutical dosage form
- Avaliação da estabilidade da Finasterida, estudos de compatibilidade fármaco-excipientes e controle de qualidade das formulações farmacêuticas sólidas do mercado
- Stability and efficacy of green solvent and natural excipient-based semisolid formulations compared with conventional formulations: a review
Community 10 of 50
- Pelage Pharmaceutical Raises 120 million to continue PP405 Research. Link inside.
- Kintor Pharmaceutical’s KX-826 Shows Promising Results in Hair Loss Study
- Cosmo Pharmaceutical (Breezula) fiscal results. Top Line Six month results expected early in the second half of this year.
- JW Pharmaceutical shows superiority of 'JW0061' in hair growth over existing treatments in US
- Pelage Pharmaceuticals Phase 3 Trials for PP405 Start in September 2026
- Pelage Pharmaceuticals posted a tweet about PP405.
- Pelage Pharmaceuticals with an absolute stunner of a molecule
- Pelage Pharmaceuticals’ PP405 and its Impact on Follicular Regeneration to be Presented at the American Academy of Dermatology (AAD) Annual Meeting 2026 28th march
- Pelage Pharmaceuticals’ PP405 and its Impact on Follicular Regeneration to be Presented at the American Academy of Dermatology (AAD) Annual Meeting 2026
- Pelage Pharmaceuticals' PP405 listed on Time Magazine's List of Best Inventions of 2025
Learn
— no results
Try a deeper search in learn →